Recently Added |view more
Cedars-Sinai Cancer provides an equitable and inclusive future in cancer research and clinical care for a diverse population by targeting every level of learner—from high school students through senior faculty.
Multidisciplinary teams of Cedars-Sinai researchers advance emerging technologies, such as AI and proteomics, to establish new norms in oncology practice.
Converting data and science into medical progress requires a strategic emphasis on work that matters to patients, either through imminent application to clinical practice or potentially transformative basic discoveries.
The breadth and richness of basic science research underway at Cedars-Sinai Cancer has wide-ranging implications that alter the approach to cancer care—and future research—here and around the world.
When Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, joined Cedars-Sinai in 2018, he launched a multimillion-dollar initiative to grow the size, reputation and impact of the center.
Medical Center Named to Honor Roll for Eighth Consecutive Year in U.S. News & World Report’s Annual “Best Hospitals” Analysis; Also Tied for #1 in California and Los Angeles, and Ranked Nationally in 11 Medical Specialties
Monday, February 12, 2024 9:30 AM
Wednesday, February 7, 2024 9:30 AM
Thursday, February 1, 2024 9:00 AM